CLL requiring treatment develops in subjects with CLL-phenotype MBL and with lymphocytosis at the rate of 1.1% per year.

• 在有CLL-表型的单克隆B淋巴细胞增多和以每年1.；1%25速度增加的淋巴细胞增多症患者需要CLL的治疗。